Sales Growth YoY (Last 12 Months): Minerva (NERV)

Graphic logo of Minerva Neurosciences (NERV)

Sales dynamics based on the rolling 12-month year-over-year growth rate are tied to the FDA approval of roluperidone. The model relies on full outsourcing of production and testing, while patent protection creates a significant barrier to entry. Meanwhile, 0.00 records a new level, visualizing the market consensus regarding the revenue expansion rates of Minerva Neurosciences (NERV).

Minerva Neurosciences, Inc. (NERV) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Minerva (NERV)

- company stock exchange capitalization indicators:
Analysis of all company metrics:NERV Minerva Neurosciences Corp
Brand item of Minerva Neurosciences Corp

Effective asset selection requires a rigorous analysis of revenue dynamics to assess business viability. This indicator measures the daily change in aggregate revenues over a rolling year, reflecting the actual pace of commercial development. For Minerva Neurosciences (NERV), amid regulatory risks and tightening liquidity, this parameter becomes a critical marker of survival. The current value of 0.00 confirms a stage of financial instability. Evaluate the LTM annual sales growth rate as a signal of the issuer's potential resource depletion.

Who Minerva Neurosciences competes with

Annual Revenue Growth (Last Twelve Months) Biogen Idec (BIIB)|NBIX - Sales Growth YoY (Last Twelve Months)|Revenue Dynamics YoY (Last Twelve Months) RGC (Regencell Bioscience)|AXSM: Sales Growth YoY (TTM)|ACADIA Pharma (ACAD) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Xenon Corp|VKTX: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) SUPN|Sales Growth YoY (TTM) catalystpharma.com (CPRX)|Sales Growth YoY (Last Twelve Months) Denali Therapeutics DNLI|HRMY - Revenue Growth YoY (Last 12 Months)|Biohaven Pharmaceutical - Sales Growth YoY (TTM)|Amylyx (AMLX) - Revenue Growth YoY (Last 12 Months)|TRVI (Trevi Pharma) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth praxismedicines.com (PRAX)|AVXL (Anavex Life Sciences Corp) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) CBLL|Revenue Growth YoY (Last 12 Months) PRTA (prothena.com)|Alector - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) ANNX (Annexon Biosciences)|OMER: Sales Growth YoY (Last 12 Months)|NGNE - Sales Growth YoY (Last Twelve Months)|ACIU - Sales Growth YoY (TTM)|Voyager Corp (VYGR) - Sales Growth YoY (Last Twelve Months)|NMRA - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Scilex|TVGN (Tevogen Bio) - Revenue Change YoY (Last 12 Months)|Revenue Growth YoY (Last 12 Months) ACOG (alphacognition.com)|Annual Revenue Growth (Last Twelve Months) Cognition Therapeutics, Inc.|Sales Growth YoY (TTM) IKT (Inhibikase Pharma)|Sales Growth YoY (TTM) Cassava Sciences, Inc. SAVA|ASRT - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Sales Growth YoY (Last Twelve Months)|OVID - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Acumen Pharmaceuticals, Inc|Sales Growth YoY (Last Twelve Months) CRVO|Sales Growth YoY (TTM) ATHE|Clene - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) PEPG (pepgen.com)|JUNS: Sales Growth YoY (Last 12 Months)|RLMD - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Firefly Neuroscience (AIFF)|Revenue Growth YoY (Last 12 Months) KLTO|NRSN: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Reviva Pharmaceuticals Holdings (RVPH)|Revenue Growth YoY (Last 12 Months) MetaVia, Inc. MTVA|Sales Growth YoY (Last Twelve Months) NeurAxis NRXS|HSDT: Sales Growth YoY (Last 12 Months)|passagebio.com - Sales Growth YoY (TTM)|NEUP - Sales Growth YoY (TTM)|Athira Pharma (ATHA) - Sales Growth YoY (Last Twelve Months)|Addex Therapeutics, Ltd. - Revenue Dynamics YoY (Last Twelve Months)|ALZN (Alzamend Neuro) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cyclerion.com CYCN|Sales Growth YoY (TTM) PTIX|KTTA - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Trailing Twelve Months Revenue Growth|BCLI - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth caratherapeutics.com|CHRO: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Longboard|Sales Growth YoY (TTM) MRNS|Annual Revenue Growth (Last Twelve Months) nkgenbiotech.com|Sales Growth YoY (TTM) NRBO (neurobopharma.com)|Sage Therapeutics, Inc (SAGE) - Trailing Twelve Months Revenue Growth|SNPX - Sales Growth YoY (Last Twelve Months)|Revenue Dynamics YoY (Last Twelve Months) TRVN (Trevena, Inc)|VIGL: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth anewmeds.com (WENA)|Revenue Growth YoY (Last 12 Months) CERE